• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过抗体水平的混合建模来量化以前的 SARS-CoV-2 感染。

Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels.

机构信息

International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK.

Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

出版信息

Nat Commun. 2021 Oct 26;12(1):6196. doi: 10.1038/s41467-021-26452-z.

DOI:10.1038/s41467-021-26452-z
PMID:34702829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8548402/
Abstract

As countries decide on vaccination strategies and how to ease movement restrictions, estimating the proportion of the population previously infected with SARS-CoV-2 is important for predicting the future burden of COVID-19. This proportion is usually estimated from serosurvey data in two steps: first the proportion above a threshold antibody level is calculated, then the crude estimate is adjusted using external estimates of sensitivity and specificity. A drawback of this approach is that the PCR-confirmed cases used to estimate the sensitivity of the threshold may not be representative of cases in the wider population-e.g., they may be more recently infected and more severely symptomatic. Mixture modelling offers an alternative approach that does not require external data from PCR-confirmed cases. Here we illustrate the bias in the standard threshold-based approach by comparing both approaches using data from several Kenyan serosurveys. We show that the mixture model analysis produces estimates of previous infection that are often substantially higher than the standard threshold analysis.

摘要

随着各国决定疫苗接种策略和如何放宽流动限制,估算先前感染 SARS-CoV-2 的人群比例对于预测 COVID-19 的未来负担非常重要。通常通过两步从血清学调查数据中估算这一比例:首先计算超过阈值抗体水平的比例,然后使用外部敏感性和特异性估计值对粗略估计进行调整。这种方法的一个缺点是,用于估计阈值敏感性的 PCR 确诊病例可能不能代表更广泛人群中的病例 - 例如,它们可能最近感染且症状更严重。混合模型提供了一种不需要来自 PCR 确诊病例的外部数据的替代方法。在这里,我们使用来自肯尼亚几项血清学调查的数据比较了这两种方法,说明了标准阈值方法的偏差。我们表明,混合模型分析产生的先前感染估计值通常远高于标准阈值分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec87/8548402/a0ad65dfe7b7/41467_2021_26452_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec87/8548402/6733d250913d/41467_2021_26452_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec87/8548402/7ae61f745ec7/41467_2021_26452_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec87/8548402/a0ad65dfe7b7/41467_2021_26452_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec87/8548402/6733d250913d/41467_2021_26452_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec87/8548402/7ae61f745ec7/41467_2021_26452_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec87/8548402/a0ad65dfe7b7/41467_2021_26452_Fig3_HTML.jpg

相似文献

1
Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels.通过抗体水平的混合建模来量化以前的 SARS-CoV-2 感染。
Nat Commun. 2021 Oct 26;12(1):6196. doi: 10.1038/s41467-021-26452-z.
2
Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.利用无截断方法估算存在不完善血清学检测的 SARS-CoV-2 的累积发病率。
PLoS Comput Biol. 2021 Feb 26;17(2):e1008728. doi: 10.1371/journal.pcbi.1008728. eCollection 2021 Feb.
3
Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands.估算一般人群中 SARS-CoV-2 感染的无症状比例:荷兰全国血清学调查数据分析。
Eur J Epidemiol. 2021 Jul;36(7):735-739. doi: 10.1007/s10654-021-00768-y. Epub 2021 Jun 10.
4
Evaluation of the performance of SARS--CoV--2 antibody assays for a longitudinal population-based study of COVID--19 spread in St. Petersburg, Russia.评估 SARS-CoV-2 抗体检测在俄罗斯圣彼得堡进行的 COVID-19 传播纵向基于人群研究中的表现。
J Med Virol. 2021 Oct;93(10):5846-5852. doi: 10.1002/jmv.27126. Epub 2021 Jun 12.
5
Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?血清阳性率估计对严重急性呼吸综合征冠状病毒 2 有偏差吗?
J Infect Dis. 2020 Nov 9;222(11):1772-1775. doi: 10.1093/infdis/jiaa523.
6
High-Throughput Multiplex SARS-CoV-2 IgG Microsphere Immunoassay for Dried Blood Spots: A Public Health Strategy for Enhanced Serosurvey Capacity.高通量多重 SARS-CoV-2 IgG 微球免疫分析检测干血斑:增强血清学调查能力的公共卫生策略。
Microbiol Spectr. 2021 Sep 3;9(1):e0013421. doi: 10.1128/Spectrum.00134-21. Epub 2021 Jul 28.
7
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.在 2019 年冠状病毒病疫情后,对一个经过全面 PCR 检测的社区使用六种不同血清学检测方法进行抗体反应的研究——CoNAN 研究。
Clin Microbiol Infect. 2021 Mar;27(3):470.e1-470.e9. doi: 10.1016/j.cmi.2020.11.009. Epub 2020 Nov 20.
8
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原和基于分子的检测。
Cochrane Database Syst Rev. 2021 Mar 24;3(3):CD013705. doi: 10.1002/14651858.CD013705.pub2.
9
Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.无症状 SARS-CoV-2 感染病例的血清学调查显示,抗体反应较弱且逐渐减弱。
Emerg Microbes Infect. 2021 Dec;10(1):905-912. doi: 10.1080/22221751.2021.1919032.
10
Antibody tests for identification of current and past infection with SARS-CoV-2.用于识别当前和既往感染新型冠状病毒2的抗体检测。
Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652.

引用本文的文献

1
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors: a systematic review and meta-analysis.健康献血者中 SARS-CoV-2 抗体的血清流行率:系统评价和荟萃分析。
BMC Public Health. 2024 Oct 22;24(1):2925. doi: 10.1186/s12889-024-20364-5.
2
Estimating cutoff values for diagnostic tests to achieve target specificity using extreme value theory.应用极值理论估计诊断试验的截断值以达到目标特异性。
BMC Med Res Methodol. 2024 Feb 8;24(1):30. doi: 10.1186/s12874-023-02139-5.
3
A Mixture Model for Estimating SARS-CoV-2 Seroprevalence in Chennai, India.

本文引用的文献

1
Stan: A Probabilistic Programming Language.斯坦:一种概率编程语言。
J Stat Softw. 2017;76. doi: 10.18637/jss.v076.i01. Epub 2017 Jan 11.
2
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21.肯尼亚三家转诊医院产前护理诊所的 SARS-CoV-2 IgG 血清监测:2020-21 年重复横断面调查。
PLoS One. 2022 Oct 14;17(10):e0265478. doi: 10.1371/journal.pone.0265478. eCollection 2022.
3
COVID-19 transmission dynamics underlying epidemic waves in Kenya.
用于估计印度钦奈地区 SARS-CoV-2 血清流行率的混合模型。
Am J Epidemiol. 2023 Sep 1;192(9):1552-1561. doi: 10.1093/aje/kwad103.
4
SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021.2020年12月至2021年5月,肯尼亚三个健康与人口监测点的新冠病毒血清流行率
PLOS Glob Public Health. 2022 Aug 18;2(8):e0000883. doi: 10.1371/journal.pgph.0000883. eCollection 2022.
5
A Bayesian approach to estimating COVID-19 incidence and infection fatality rates.一种用于估计新冠病毒感染率和感染死亡率的贝叶斯方法。
Biostatistics. 2024 Apr 15;25(2):354-384. doi: 10.1093/biostatistics/kxad003.
6
Serology Assays Used in SARS-CoV-2 Seroprevalence Surveys Worldwide: A Systematic Review and Meta-Analysis of Assay Features, Testing Algorithms, and Performance.全球范围内用于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)血清流行率调查的血清学检测方法:检测方法特征、检测算法及性能的系统评价和荟萃分析
Vaccines (Basel). 2022 Nov 24;10(12):2000. doi: 10.3390/vaccines10122000.
7
Field evaluation of rapid diagnostic tests to determine dengue serostatus in Timor-Leste.东帝汶登革热血清学检测的现场评估。
PLoS Negl Trop Dis. 2022 Nov 7;16(11):e0010877. doi: 10.1371/journal.pntd.0010877. eCollection 2022 Nov.
8
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21.肯尼亚三家转诊医院产前护理诊所的 SARS-CoV-2 IgG 血清监测:2020-21 年重复横断面调查。
PLoS One. 2022 Oct 14;17(10):e0265478. doi: 10.1371/journal.pone.0265478. eCollection 2022.
9
Informing healthcare operations with integrated pathology, clinical, and epidemiology data: Lessons from a single institution in Kenya during COVID-19 waves.利用综合病理学、临床和流行病学数据为医疗保健运营提供信息:COVID-19疫情期间肯尼亚一家机构的经验教训。
Front Med (Lausanne). 2022 Sep 6;9:969640. doi: 10.3389/fmed.2022.969640. eCollection 2022.
10
Serology as a Tool to Assess Infectious Disease Landscapes and Guide Public Health Policy.血清学作为评估传染病态势和指导公共卫生政策的工具。
Pathogens. 2022 Jun 27;11(7):732. doi: 10.3390/pathogens11070732.
肯尼亚疫情波次中 COVID-19 的传播动力学。
Science. 2021 Nov 19;374(6570):989-994. doi: 10.1126/science.abk0414. Epub 2021 Oct 7.
4
Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.人群中 SARS-CoV-2 的暴露水平比血清流行率调查所显示的要高得多。
PLoS Comput Biol. 2021 Sep 20;17(9):e1009436. doi: 10.1371/journal.pcbi.1009436. eCollection 2021 Sep.
5
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗体的强度和可检测性受疾病严重程度、时间以及检测方法的影响。
Sci Adv. 2021 Jul 30;7(31). doi: 10.1126/sciadv.abh3409. Print 2021 Jul.
6
SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study.英国一个极端正统犹太社区的新冠病毒血清流行率:一项回顾性队列研究。
Lancet Reg Health Eur. 2021 Jul;6:100127. doi: 10.1016/j.lanepe.2021.100127.
7
Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.肯尼亚新冠疫情第一波期间新冠病毒血清阳性率的时间趋势
Nat Commun. 2021 Jun 25;12(1):3966. doi: 10.1038/s41467-021-24062-3.
8
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.SARS-CoV-2 中和抗体反应动力学和免疫持久性:一项纵向研究。
Lancet Microbe. 2021 Jun;2(6):e240-e249. doi: 10.1016/S2666-5247(21)00025-2. Epub 2021 Mar 23.
9
Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin.市售 SARS-CoV-2 IgG ELISA 在非洲来源血清样本中的特异性有限。
Trop Med Int Health. 2021 Jun;26(6):621-631. doi: 10.1111/tmi.13569. Epub 2021 Apr 5.
10
Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.利用无截断方法估算存在不完善血清学检测的 SARS-CoV-2 的累积发病率。
PLoS Comput Biol. 2021 Feb 26;17(2):e1008728. doi: 10.1371/journal.pcbi.1008728. eCollection 2021 Feb.